Evidence map›Paper›PMID 40283459›Full record

ReviewJournal of clinical medicine2025

Rethinking the Assessment of Arthrogenic Muscle Inhibition After ACL Reconstruction: Implications for Return-to-Sport Decision-Making-A Narrative Review.

Florian Forelli, Ayrton Moiroux-Sahraoui, Jean Mazeas, Jonathan Dugernier, Adrien Cerrito

Abstract readReview
In one paragraph

Review in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Periodization in Orthobiologics Rehabilitation.Journal of clinical medicine · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Florian ForelliHaute-Ecole Arc Santé, HES-SO University of Applied Sciences and Arts Western Switzerland, 2800 Delémont, Switzerland.ORCID 0000-0001-8650-2746
Ayrton Moiroux-SahraouiOrthopaedic Surgery Department, Clinic of Domont, Ramsay Healthcare, @OrthoLab, 95330 Domont, France.ORCID 0009-0005-2654-2195
Jean MazeasOrthopaedic Surgery Department, Clinic of Domont, Ramsay Healthcare, @OrthoLab, 95330 Domont, France.ORCID 0009-0000-6322-7091
Jonathan DugernierHaute-Ecole Arc Santé, HES-SO University of Applied Sciences and Arts Western Switzerland, 2800 Delémont, Switzerland.ORCID 0000-0001-6567-8523
Adrien CerritoHaute-Ecole Arc Santé, HES-SO University of Applied Sciences and Arts Western Switzerland, 2800 Delémont, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Arthrogenic muscle inhibition (AMI) is a neuromuscular impairment commonly observed following anterior cruciate ligament reconstruction (ACLR). This condition, characterized by persistent quadricep inhibition due to altered afferent feedback, significantly impacts neuromuscular recovery, delaying return to running and sport. Despite advancements in rehabilitation strategies, AMI may persist for months or even years after ACLR, leading to muscle strength asymmetries, altered biomechanics, and an increased risk of reinjury. The mechanisms underlying AMI involve both peripheral (joint effusion, mechanoreceptor dysfunction) and central (corticospinal inhibition, neuroplasticity alterations) components, which collectively hinder voluntary muscle activation and movement control. AMI alters gait mechanics, reduces knee stability, and promotes compensatory patterns that increase injury risk. Current return-to-sport protocols emphasize strength symmetry and functional performance but often neglect neuromuscular deficits. A comprehensive assessment integrating neuromuscular, biomechanical, and proprioceptive evaluations is needed at specific stages to optimize rehabilitation and minimize reinjury risk. Future research should explore targeted interventions such as neuromuscular stimulation, cognitive-motor training, and advanced gait analysis to mitigate AMI's impact and facilitate a safer, more effective return to sport.

Indexed as

anterior cruciate ligament reconstructionarthrogenic muscle inhibitionbiomechanicsneuromuscular recoveryreturn to sport

Identifiers

PMID40283459
PMCPMC12027548

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.